FY2026 List of Projects - Research Program on HIV/AIDS
| First Year | Final Year | Principal Investigator | Affiliation | Project Title | |
|---|---|---|---|---|---|
| FY2024 | FY2026 | MATANO Tetsuro | Japan Institute for Health Security | Director-General | Study for the development of a therapeutic HIV vaccine inducing CD8+ T cell responses |
| FY2024 | FY2026 | TACHIKAWA Ai | Japan Institute for Health Security | Division leader | Development of new T cell immunotherapies for HIV cure/remission |
| FY2024 | FY2026 | OHMORI Tsukasa | Jichi Medical University | Professor | Development of innovative therapies and treatment systems aimed at solving issues for hemophilia |
| FY2024 | FY2026 | TERUYA Katsuji | Japan Institute for Health Security | Clinical Director | Study on appropriate management of opportunistic illnesses in the era of early and prolonged ART |
| FY2024 | FY2026 | UENO Takamasa | Kumamoto University | Professor | Effect of nucleoside modifications on viral replication and disease phenotypes during HIV-1 infection |
| FY2024 | FY2026 | SUZUKI Youichi | Osaka Medical and Pharmaceutical University | Special Duties Charge teacher Professor | Elucidation of the molecular and structural basis for the multifunctionality of HIV RNA toward development of novel anti-HIV agents |
| FY2024 | FY2026 | MONDE Kazuaki | Kumamoto University | Lecturer | Study of host factor roles for HIV-1 release using the visualization technology |
| FY2024 | FY2028 | YAMAMOTO Hiroyuki | Japan Institute for Health Security | Director | Immune control of HIV and antagonism of HIV pathogenesis by immunosignaling stoichiometric analysis and discovery/ characterization of human inborn errors of immunity |
| FY2024 | FY2026 | URANO Emiko | National Institutes of Biomedical Innovation Health and Nutrition | Senior Researcher | Study of novel therapy development for HIV/AIDS using innovative antibody technologies |
| FY2024 | FY2026 | KUSE Nozomi | Japan Institute for Health Security | Senior Researcher | Identification of novel factors to enhance HIV-1-specific T cell functions toward a functional cure for HIV-1 |
| FY2024 | FY2026 | SUKEGAWA Sayaka | Institute of Science Tokyo | Junior Associate Professor (Career Track) | Identification and characterization of hMRC1-associated host factor(s) involved in regulating HIV-1 replication in macrophages |
| FY2025 | FY2027 | SATOU Yorifumi | Hokkaido University | Professor | Research on elucidating HIV latency mechanisms and developing a viral reservoir evaluation system using next-generation analytical technologies |
| FY2025 | FY2027 | YAMAMOTO Takuya | National Institutes of Biomedical Innovation Health and Nutrition | Director | Research and development aiming for the functional cure of HIV-1 based on RNA technology |
| FY2025 | FY2027 | KIKUCHI Tadashi | Japan Institute for Health Security | Senior Researcher | Study of long-term trend of circulating HIV strains and HIV drug resistance in Japan |
| FY2025 | FY2027 | KIMURA Kiminori | Tokyo Metropolitan Hospital Organization Tokyo Metropolitan Komagome Hospital | Director | Development of anti-fibrotic therapeutic agent in liver cirrhosis caused by HIV/HCV co-infection complicated with hemophilia |
| FY2025 | FY2027 | MIZUSHIMA Daisuke | Japan Institute for Health Security | Director | Study of the diagnostic utility of liquid biopsy on HPV-related cancer in a prospective cohort |
| FY2025 | FY2029 | SAITO Akatsuki | University of Miyazaki | Associate Professor | HIV cure strategy utilizing innovative protein delivery systems |
| FY2025 | FY2027 | ISHIZAKA Aya | Japan Institute for Health Security | Senior Research Scientist | Studies on intestinal bacteria-derived extracellular vesicles and persistent inflammation in people with HIV |
| FY2025 | FY2027 | CHIKATA Takayuki | Japan Institute for Health Security | Senior Research Fellow | Study of NK cell leads to immunotherapy for HIV cure |
| FY2025 | FY2027 | MACHIDA Shinichi | Japan Institute for Health Security | Director | Structural and functional analysis of HIV capsid complexes for therapeutic development |
| FY2026 | FY2028 | MIYAUCHI Kosuke | RIKEN | Team director | Study of the mouse model for chronic infection of MLV/HIV chimera-virus |
| FY2026 | FY2028 | IWATANI Yasumasa | Hamamatsu University School of Medicine | Professor | Basic research and development for ensuring long-term treatment with the anti-HIV-1 CA inhibitor |
| FY2026 | FY2028 | ISHIZAKA Yukihito | Japan Institute for Health Security | Vice Director General/Director of Intractable Diseases | Eradication of HIV-1 reservoir with engineered patient-derived hematopoietic stem cells |
Last updated 05/18/26